Molecular biology of human papillomavirus infection and cervical cancer
The DOI matches its Crossref record; 172 of the 179 references it cites were found in a registry or an index.
Abstract
HPVs (human papillomaviruses) infect epithelial cells and cause a variety of lesions ranging from common warts/verrucas to cervical neoplasia and cancer. Over 100 different HPV types have been identified so far, with a subset of these being classified as high risk. High-risk HPV DNA is found in almost all cervical cancers (>99.7%), with HPV16 being the most prevalent type in both low-grade disease and cervical neoplasia. Productive infection by high-risk HPV types is manifest as cervical flat warts or condyloma that shed infectious virions from their surface. Viral genomes are maintained as episomes in the basal layer, with viral gene expression being tightly controlled as the infected cells move towards the epithelial surface. The pattern of viral gene expression in low-grade cervical lesions resembles that seen in productive warts caused by other HPV types. High-grade neoplasia represents an abortive infection in which viral gene expression becomes deregulated, and the normal life cycle of the virus cannot be completed. Most cervical cancers arise within the cervical transformation zone at the squamous/columnar junction, and it has been suggested that this is a site where productive infection may be inefficiently supported. The high-risk E6 and E7 proteins drive cell proliferation through their association with PDZ domain proteins and Rb (retinoblastoma), and contribute to neoplastic progression, whereas E6-mediated p53 degradation prevents the normal repair of chance mutations in the cellular genome. Cancers usually arise in individuals who fail to resolve their infection and who retain oncogene expression for years or decades. In most individuals, immune regression eventually leads to clearance of the virus, or to its maintenance in a latent or asymptomatic state in the basal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“human papillomavirus (HPV) is thought to initiate cervical carcinoma and squamous cell carcinoma of the head and neck in part by inactivating RB through expression of the E7 oncoprotein21,22”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
In the citing paper
“in HPV-induced cervical cancers, the virus initiates cancer in dividing cells in the basal layer of the epithelium, preventing their normal cell cycle exit and maturation21.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Barrier Function of the Skin: “La Raison d'Être” of the Epidermis
Madison, K. C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12359.x · Cited by 1,188
Muñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,104
Clifford, G., Gallus, S., Herrero, R., Muñoz, N., Snijders, P., Vaccarella, S., Anh, P., Ferreccio, C., Hieu, N., Matos, E., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67069-9 · Cited by 1,093
Münger, K., Phelps, W. C., Bubb, V, Howley, P. M., & Schlegel, R. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4417-4421.1989 · Cited by 1,030
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., & Banks, L. (1998) · Nature · doi:10.1038/30400 · Cited by 974
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Research works printed but not linked: 2
- Villiers de, 2001, Taxonomic classification of papillomaviruses, Papillomavirus Rep., 12, 57
- Sorathia, 2004, The E4 protein of HPV16 Interacts with E2 and regulates the trans-activation and replication functions of E2, 318
Cited by
Items 101–200 of 1,000
Zielecki, F., Semmler, I., Kalthoff, D., Voß, D., Mauel, S., Gruber, A. D., Beer, M., & Wolff, T. (2010) · Journal of Virology · doi:10.1128/jvi.00610-10 · Cited by 97
“One well-studied example is the human papillomavirus E6 protein, which binds the tumor suppressor protein Scribble, resulting in a loss of epithelial cell polarization and concomitant hyperproliferation (14).”
BackgroundThomas, L. K., Bermejo, J. L., Vinokurova, S., Jensen, K., Bierkens, M., Steenbergen, R. D. M., Bergmann, M., Doeberitz, M. V. K., & Reuschenbach, M. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.08.022 · Cited by 96
“The key event for the transition from the prevalent virus particle producing ‘acute/permissive’ to the rarer ‘transforming infection’ is the deregulated expression of the viral oncogenes E6 and E7 [4,6].”
BackgroundRETRACTED ARTICLE: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis
Gupta, S. M., & Mania‐Pramanik, J. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0520-2 · Cited by 117
RetractedMiR-215 modulates gastric cancer cell proliferation by targeting RB1
Deng, Y., Zhenxia, H., Xu, Y., Jin, J. F., Zhuo, W., Zhang, C., Zhang, X., Shen, M., Yan, X., Wang, L., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.033 · Cited by 93
“Loss of function of RB drives tumorigenesis in many cancers, such as osteosarcoma [24,25], cervical carcinoma [26], squamous cell carcinoma [27], liver cancer [28], small-cell lung carcinomas [29], and gastric cancer [30–32].”
BackgroundMbulawa, Z. Z. A., Marais, D. J., Johnson, L. F., Coetzee, D. J., & Williamson, A. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis299 · Cited by 91
Analysis of Host–Parasite Incongruence in Papillomavirus Evolution Using Importance Sampling
Shah, S. D., Doorbar, J., & Goldstein, R. A. (2010) · Molecular Biology and Evolution · doi:10.1093/molbev/msq015 · Cited by 109
“…regress spontaneously although persistent infection of a subset of these viruses can lead to the formation of malignant tumors (Durst et al. 1983; Boshart et al. 1984; zur Hausen 1989, 2000; Ho et al. 1995; Campo 2002; Ferenczy and Franco 2002; Pfister 2003; Schiffman et al. 2005; Doorbar 2006).”
BackgroundSelf-citationMoscicki, A., Shi, B., Huang, H., Barnard, E., & Li, H. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.569022 · Cited by 104
“…cervix, human papillomavirus INTRODUCTION The oncogenic capabilities of high risk human papillomavirus (hrHPV), the cause of cervical cancers, are well-known and include cell cycle deregulation, interference with telomerase activity and apoptosis (Doorbar, 2006; Wise-Draper and Wells, 2008).”
BackgroundMolecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung
Robinson, L. A., Jaing, C. J., Pierce, C. M., Magliocco, A. M., Xiong, Y., Magliocco, G., Thissen, J. B., & Antonia, S. J. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.213 · Cited by 92
“Perhaps the strongest documented causal relationship exists for HPV, which causes 99% of cervical cancers, 90% of anal cancers, 50% of penile, vulvar and vaginal cancers, and 470% of oropharyngeal cancers (Doorbar, 2006; Chaturvedi et al, 2011).”
BackgroundEgawa, N., Nakahara, T., Ohno, S.-I., Narisawa‐Saito, M., Yugawa, T., Fujita, M., Yamato, K., Natori, Y., & Kiyono, T. (2012) · Journal of Virology · doi:10.1128/jvi.06450-11 · Cited by 86
“PVs establish long-term persistent infections in squamous epithelium, and the viral life cycle is tightly linked with the differentiation state of the host keratinocytes (7).”
BackgroundDetection of human papillomavirus in human focal cortical dysplasia type IIB
Chen, J., Tsai, V., Parker, W. E., Aronica, E., Baybis, M., & Crino, P. B. (2012) · Annals of Neurology · doi:10.1002/ana.23795 · Cited by 84
“Other genomic components of HPV16 such as E1 and E4 may not be detected in middle to late stage cervical dysplasia.(21) Interestingly, severe cervical dysplasia and cervical cancer contain integrated HPV genomes expressing exclusively E6 and E7 rather than episomes capable of producing more assembled virus.”
BackgroundMiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer
Wang, F., Shan, S., Huo, Y., Xie, Z., Fang, Y., Qi, Z., Chen, F., Li, Y., & Sun, B. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.04.005 · Cited by 85
Prowse, D. M., Ktori, E., Chandrasekaran, D., Prapa, A., & Baithun, S. I. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08305.x · Cited by 93
Expression of CPEB, GAPDH and U6snRNA in cervical and ovarian tissue during cancer development
HANSEN, C. N., Ketabi, Z., Rosenstierne, M. W., Palle, C., Boesen, H. C., & Norrild, B. (2009) · Apmis · doi:10.1111/j.1600-0463.2008.00015.x · Cited by 90
“During HPV-induced cancer development the HPV genome is most often integrated into the host cell genome (23).”
BackgroundIsaacson Wechsler, E., Wang, Q., Roberts, I., Pagliarulo, E., Jackson, D., Untersperger, C., Coleman, N., Griffin, H., & Doorbar, J. (2012) · Journal of Virology · doi:10.1128/jvi.07069-11 · Cited by 83
“Since E6 and E7 are known to interfere with cellular proteins important for regulating cellular growth (4, 6, 14, 21), we next examined whether these proteins showed any correlation with the different HPV16 phenotypes.”
BackgroundSelf-citationAdsorption of Human Papillomavirus 16 to Live Human Sperm
Perez, J. D., Buck, C. B., & Ribbeck, K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005847 · Cited by 84
“Although many HPV infections remain clinically inconspicuous or develop benign symptoms such as warts (papillomas), a subset of infections lead to cancer of the uterine cervix [3–5].”
BackgroundMolecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer
Faraji, F., Zaidi, M. A., Fakhry, C., & Gaykalova, D. A. (2017) · Microbes and Infection · doi:10.1016/j.micinf.2017.06.001 · Cited by 98
Burd, E. M., & Dean, C. L. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0001-2015 · Cited by 101
“L2 is thought to also be involved in allowing the viral genome to enter the host cell nucleus where replication ensues via proteins E1 and E2 as well as the host cell’s replication machinery (7, 12).”
Polyethylenimine Is a Strong Inhibitor of Human Papillomavirus and Cytomegalovirus Infection
Spoden, G. A., Besold, K., Krauter, S., Plachter, B., Hanik, N., Kilbinger, A. F. M., Lambert, C., & Florin, L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05147-11 · Cited by 103
“High-risk HPV types, including HPV type 16 (HPV16), HPV18, and HPV31, are associated with anogenital malignancies and are etiologically linked to the development of cervical cancer (16).”
BackgroundJain, M., Yadav, D., Jarouliya, U., Chavda, V. K., Yadav, A. K., Chaurasia, B. K., & Song, M. (2023) · Pathogens · doi:10.3390/pathogens12121380 · Cited by 100
“In basal or para-basal cells, E6 and E7 proteins are expressed to stimulate cell division in the epithelium [10,81].”
BackgroundYao, S., Xu, J., Zhao, K., Song, P., Yan, Q., Fan, W., Wan, L., & Lu, C. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1059-y · Cited by 84
Tummers, B., Goedemans, R., Pelascini, L. P. L., Jordanova, E. S., van Esch, E. M. G., Meyers, C., Melief, C. J. M., Boer, J. M., & van der Burg, S. H. (2015) · Nature Communications · doi:10.1038/ncomms7537 · Cited by 81
“HrHPV infections can last up to 2 years despite viral activity in infected KCs, the expression of viral antigens and the presence of KC-expressed pattern recognition receptors (PRRs) 1–4 that should lead to activation of innate and adaptive immune responses.”
Role of Zn 2+ Ions in Host-Virus Interactions
Lazarczyk, M. J., & Fãvre, M. (2008) · Journal of Virology · doi:10.1128/jvi.01314-08 · Cited by 83
“Therefore, E5 is thought to be involved in the coordination of the HPV life cycle and is important mainly during the productive stages (11).”
BackgroundZheng, D.-D., Fu, D., Wu, Y., Sun, Y., Tan, L., Zhou, T., Ma, S., Zha, X., & Yang, Y. (2014) · Chemical Communications · doi:10.1039/c3cc49789e · Cited by 82
Cancer vaccines: Looking to the future
Yaddanapudi, K., Mitchell, R. A., & Eaton, J. W. (2013) · OncoImmunology · doi:10.4161/onci.23403 · Cited by 93
“Food and Drug Administration (FDA) has approved two prophylactic vaccines against human papillomavirus (HPV), Gardasil and Cervarix, protecting against infection by the two types of HPV (type 16 and 18) that cause approximately 70 percent of all cases of cervical cancer worldwide.(7,8) Both vaccines are derived from v…”
Characterization of molecular markers indicative of cervical cancer progression
Arnouk, H., Merkley, M. A., Podolsky, R. H., Stöppler, H., Santos, C., Alvarez, M. G., Mariátegui, J. C., Ferris, D. G., Lee, J. R., & Dynan, W. S. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800068 · Cited by 87
“HPV E6 and E7 bind directly to p53, Rb, and a number of other cellular proteins (reviewed in references [10,11]).”
BackgroundCattani, P., Zannoni, G. F., Ricci, C., D’Onghia, S., Trivellizzi, I. N., Franco, A. D., Vellone, V. G., Durante, M., Fadda, G., Scambia, G., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01275-09 · Cited by 88
“The loss of the L1 gene and its impact on viral replication after integration could lead to relatively low viral loads (7, 15, 24, 32).”
BackgroundResultNatural History of Human Papillomavirus Infection
Ki, E. Y., & Park, J. S. (2014) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-014-0082-y · Cited by 80
Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma
Lie, A. K., & Kristensen, G. B. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.4.405 · Cited by 90
Doeberitz, M. V. K., Reuschenbach, M., Schmidt, D., & Bergeron, C. (2012) · Expert Review of Proteomics · doi:10.1586/epr.12.13 · Cited by 94
Molecular mechanisms of tumor suppression by LKB1
Vaahtomeri, K., & Mäkelä, T. P. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.12.034 · Cited by 87
“HPV E6 and E7 inactivate p53 and retinoblastoma (pRB) functions [21], and a further promoter of”
BackgroundOrth, G., Jablonska, S., Breitburd, F., Fãvre, M., & Croissant, O. (2013) · American Academy of Pediatrics eBooks · doi:10.1542/9781581107951-ch90 · Cited by 77
Waldstrøm, M., Christensen, R. K., & Ørnskov, D. (2012) · Cancer Cytopathology · doi:10.1002/cncy.21233 · Cited by 78
“Persistent infection with oncogenic types of HPV is crucial to the development of CIN3 and cervical cancer, and is caused by a shift in viral gene expression, resulting in enhanced expression of the 2 major oncogenes E6 and E7.”
BackgroundChih, H., Lee, A. H., Colville, L., Binns, C. W., & Xu, D. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2013.757630 · Cited by 76
Himawan, A., Vora, L. K., Permana, A. D., Sudir, S., Nurdin, A. R., Nislawati, R., Hasyim, R., Scott, C. J., & Donnelly, R. F. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202066 · Cited by 88
Autophagy regulation in cancer development and therapy.
White, E. J., Martín, V., Liu, J.-L., Klein, S. R., Piya, S., Gomez‐Manzano, C., Fueyo-Margareto, J., & Jiang, H. (2011) · American Journal of Cancer Research · Cited by 85
Charette, S. T., & McCance, D. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210541 · Cited by 76
“E6 degrades p53, whereas E7 is involved in deregulation of the Rb/E2F pathway (reviewed by Doorbar, 2006).”
BackgroundCancer Vaccines: Promising Therapeutics or an Unattainable Dream
Donninger, H., Li, C., Eaton, J. W., & Yaddanapudi, K. (2021) · Vaccines · doi:10.3390/vaccines9060668 · Cited by 80
Immunotherapeutic approaches for cancer therapy: An updated review
Kazemi, T., Younesi, V., Jadidi‐Niaragh, F., & Yousefi, M. (2015) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2015.1019669 · Cited by 81
“The FDA has just approved Gardasil, manufactured by Merck & Company, and Cervarix, manufactured by GlaxoSmithKline, that protect against infection by HPV—types 16 and 18—that cause approximately 70 percent of all cases of cervical cancer (Doorbar 2006).”
BackgroundMethodMazumder, D. I., Singh, R. K., Mitra, S., Dutta, S., Chakraborty, C., Basu, P. S., Mondal, R. K., Roychoudhury, S., & Panda, C. K. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.08.004 · Cited by 75
Evans, M. F., Peng, Z., Clark, K. M., Adamson, C. S.-C., Ma, X., Wu, X., Wang, H., Luo, Y., & Cooper, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091142 · Cited by 76
de la Rosa, G. P., Monroy, A., Mora‐García, M. D. L., Reynaga‐Peña, C. G., Hernández‐Montes, J., Weiss‐Steider, B., & Gómez-Lim, M. Á. (2009) · Virology Journal · doi:10.1186/1743-422x-6-2 · Cited by 72
“Background The human papillomaviruses (HPV) comprise a heterogeneous group of more than 130 epitheliotropic genotypes, 16 of which are considered "high-risk" types and linked with the development of malignant disease [1].”
BackgroundCerasuolo, A., Buonaguro, L., Buonaguro, L., & Tornesello, M. L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00474 · Cited by 78
“Briefly, the E1 and E2 proteins as well as the E6 and E7 proteins are expressed at low levels in the basal cell stratum of the cervical epithelium and become overexpressed once the keratinocytes move from the basal to the mid layers (Doorbar, 2006; Xue et al., 2010; Doorbar et al., 2012).”
BackgroundΝikolouzakis, Τ. Κ., Falzone, L., Lasithiotakis, K. G., Krüger‐Krasagakis, S., Kalogeraki, A. M., Sifaki, M., Spandidos, D. A., Chrysos, E., Tsatsakis, A. M., & Tsiaoussis, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092868 · Cited by 74
“HPV produces the E6 and E7 oncoproteins which have the potential to integrate into the hosts’ keratinocytes genome [54,55].”
BackgroundRequirement for Stromal Estrogen Receptor Alpha in Cervical Neoplasia
Chung, S., Shin, M. K., Korach, K. S., & Lambert, P. F. (2012) · Hormones and Cancer · doi:10.1007/s12672-012-0125-7 · Cited by 76
“continued growth of cervical cancer cells [40, 41], their”
Proteomic approaches to the study of papillomavirus-host interactions
White, E. A., & Howley, P. M. (2013) · Virology · doi:10.1016/j.virol.2012.09.046 · Cited by 57
“The PV replication is invariably linked to and dependent upon the differentiation of squamous epithelial cells that the virus infects (Doorbar, 2006).”
BackgroundTropé, A., Sjøborg, K., Eskild, A., Cuschieri, K. S., Eriksen, T., Thoresen, S., Steinbakk, M., Laurak, V., Jonassen, C. M., Westerhagen, U., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01863-08 · Cited by 72
“Progression to carcinoma is associated with a persistent infection with high-risk (HR) HPV types, integration of the HPV genome into the host chromosomes, and upregulation of E6 and E7 oncogenes, which can lead to abrogation of normal cell cycling events and tumor suppressor activity (7, 30, 31).”
BackgroundLiu, Y., Stewart, T. M., Casero, R. A., Kagiampakis, I., Jin, L., Zhang, J., Wang, H. H., Che, Q., Tong, H., Ke, J., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3979 · Cited by 73
“Human papilloma virus (HPV) is a small, circular, double-stranded DNA virus infecting epithelial cells and has been reported to be necessary, but not sufficient to initiate cervical squamous epithelial cell tumorigenesis (54,55).”
Detection of specific HPV subtypes responsible for the pathogenesis of condylomata acuminata
Hawkins, M. G., Winder, D. M., Ball, S. L. R., Vaughan, K., Sonnex, C., Stanley, M., Sterling, J. C., & Goon, P. K. C. (2013) · Virology Journal · doi:10.1186/1743-422x-10-137 · Cited by 70
“*The choice of E6 DNA and mRNA as a target for our qPCRs for DNA and RNA viral loads was taken because E6 and E7 are crucial early proteins active in all alphagroup papillomavirus replication, DNA synthesis, abortive infections and productive infections but not in latent infections [30-32].”
BackgroundEtiologic role of human papillomavirus infection in bladder carcinoma
Shigehara, K., Sasagawa, T., Kawaguchi, S., Nakashima, T., Shimamura, M., Maeda, Y., Konaka, H., Mizokami, A., Koh, E., & Namiki, M. (2010) · Cancer · doi:10.1002/cncr.25777 · Cited by 70
“The expression of L1 protein generally indicates HPV particle reproduction in reproductive infection.(20)”
BackgroundHuman tumour viruses and the deregulation of cell polarity in cancer
Banks, L., Pim, D., & Thomas, M. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3400 · Cited by 82
Special Issue about Head and Neck Cancers: HPV Positive Cancers
Economopoulou, P., Kotsantis, I., & Psyrri, A. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093388 · Cited by 68
“Like other host-dependent viruses, HPV uses the host cell replication machinery to initiate viral DNA replication, which is consequently promoted by E6 and E7 [7].”
BackgroundSteinestel, J., Ghazal, A. A., Arndt, A., Schnoeller, T. J., Schrader, A. J., Moeller, P. D. R., & Steinestel, K. (2015) · BMC Cancer · doi:10.1186/s12885-015-1268-z · Cited by 68
“Integration of HR-HPV DNA into the host cell genome leads to overexpression of viral oncoproteins E6 and E7 that exert a dysregulating effect on cell cycle control [6]; upregulation of tumour suppressor protein p16 is understood as an attempt to stop uncontrolled cell proliferation in response to HPV infection [7].”
BackgroundPractical issues in the application of p16 immunohistochemistry in diagnostic pathology
Mahajan, A. (2016) · Human Pathology · doi:10.1016/j.humpath.2015.12.021 · Cited by 70
“nucleus and cytoplasm as part of a positive feedback loop, which can be detected by IHC [1,2,7,15,17–21].”
BackgroundCladel, N. M., Budgeon, L. R., Cooper, T. K., Balogh, K. K., Hu, J., & Christensen, N. D. (2013) · Journal of Virology · doi:10.1128/jvi.00777-13 · Cited by 66
van der Burg, S. H., & Palefsky, J. M. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-108 · Cited by 66
Targeted Gene Delivery Therapies for Cervical Cancer
Ayén, Á., Jiménez-Martínez, Y., & Boulaiz, H. (2020) · Cancers · doi:10.3390/cancers12051301 · Cited by 66
“This gene is inactivated by E6 protein in a high percentage of cervical cancers [61], so p53 based gene therapy has been widely studied in cervical cancer.”
BackgroundHam, S., Kim, K. H., Kwon, T. H., Bak, Y., Lee, D. H., Song, Y., Park, S.-H., Park, Y. S., Kim, M. S., Kang, J. W., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3157 · Cited by 64
Molecular approaches for HPV genotyping and HPV-DNA physical status
Tsakogiannis, D., Gartzonika, C., Levidiotou-Stefanou, S., & Markoulatos, P. (2017) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2017.2 · Cited by 67
McIntosh, P. B., Laskey, P., Sullivan, K. H., Davy, C. E., Wang, Q., Jackson, D. J., Griffin, H. M., & Doorbar, J. (2010) · Journal of Cell Science · doi:10.1242/jcs.061978 · Cited by 84
“7% of cervical cancers, with alphagroup types HPV16 and HPV18 occurring most frequently (Doorbar, 2006; Walboomers et al., 1999).”
BackgroundInfluentialSelf-citationWilhelm, S., Degorce‐Rubiales, F., Godson, D. L., & Favrot, C. (2006) · Veterinary Dermatology · doi:10.1111/j.1365-3164.2006.00547.x · Cited by 63
Reuschenbach, M., Huebbers, C. U., Prigge, E., Bermejo, J. L., Kalteis, M. S., Preuss, S. F., Seuthe, I. M. C., Kolligs, J., Speel, E. M., Olthof, N. C., et al. (2015) · Cancer · doi:10.1002/cncr.29315 · Cited by 66
“Transformation by HPV is initiated at the time of overexpression of its oncogenes E6 and E7,(4,5) as reviewed by Doorbar.(6) Expression of E6 and E7 is regulated by the upstream regulatory region (URR) of the HPV genome, to which cellular and viral transcription factors can bind.”
BackgroundRole of human papillomavirus in oropharyngeal squamous cell carcinoma: A review
Woods, R., O’Regan, E. M., Kennedy, S., Martin, C. M., O’Leary, J. J., & Timon, C. V. I. (2014) · World Journal of Clinical Cases · doi:10.12998/wjcc.v2.i6.172 · Cited by 72
Firnhaber, C. S., Zungu, K., Levin, S., Michelow, P., Montaner, L. J., McPhail, P., Williamson, A., Allan, B., van der Horst, C., Rinas, A., et al. (2009) · Acta Cytologica · doi:10.1159/000325079 · Cited by 73
Wilting, S. M., Steenbergen, R. D. M., Tijssen, M., van Wieringen, W. N., Helmerhorst, T. J. M., van Kemenade, F. J., Bleeker, M. C. G., van de Wiel, M. A., Carvalho, B. G., Meijer, G. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2478 · Cited by 62
Hyperthermia Selectively Targets Human Papillomavirus in Cervical Tumors via p53-Dependent Apoptosis
Oei, A. L., van Leeuwen, C. M., ten Cate, R., Rodermond, H. M., Buist, M. R., Stalpers, L. J. A., Crezee, J., Kok, H. P., Medema, J. P., & Franken, N. A. P. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0816 · Cited by 64
“HPV is associated with several types of cancers, such as carcinoma of the head and neck, anus, vagina, vulva and penis (Doorbar, 2006; Jayaprakash et al, 2011; Watson et al, 2008).”
BackgroundShamsipur, M., Nasirian, V., Mansouri, K., Barati, A., Veisi-Raygani, A., & Kashanian, S. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.01.002 · Cited by 62
Conesa‐Zamora, P. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.08.025 · Cited by 61
“In the upper epithelial layers where the cells become exfoliated the HPV expresses L1 and L2 proteins which assemble to construct the viral capsid which permits the packaging of the replicated genomes and the viral spread [4].”
BackgroundTelomerase Induction in HPV Infection and Oncogenesis
Katzenellenbogen, R. A. (2017) · Viruses · doi:10.3390/v9070180 · Cited by 66
“In the basal layer, the HPV genome escapes its viral capsid and is maintained at 50–60 copies per cells (ranging from 10 to 200 copies) [2,6], while the early (E) viral genes are expressed.”
BackgroundBovine papillomavirus DNA can be detected in keratinocytes of equine sarcoid tumors
Bogaert, L., Martens, A., Kast, W. M., Marck, E. V., & Cock, H. D. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2010.05.032 · Cited by 61
Debata, P. R., Castellanos, M. R., Fata, J. E., Baggett, S., Rajupet, S. R., Szerszen, A., Begum, S., Mata, A., Murty, V. V. V. S., Opitz, L. M., et al. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.12.005 · Cited by 59
“The transforming antigens E6 and E7, which complex with p53 and Rb, respectively, trigger degradation of these cell cycle inhibitors [37,38].”
BackgroundStabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance
Nicolaides, L., Davy, C., Raj, K., Kranjec, C., Banks, L., & Doorbar, J. (2011) · Virology · doi:10.1016/j.virol.2011.03.017 · Cited by 53
“These cells divide, and as they move towards the surface of the epithelium they differentiate, triggering expression of the different viral proteins and viral DNA amplification (reviewed in Doorbar, 2006).”
Self-citationClinical relevance and implications of HPV-induced neoplasia in different anatomical locations
Prigge, E. S., Doeberitz, M. V. K., & Reuschenbach, M. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.06.005 · Cited by 67
“numbers, packaging and release of newly synthesized, infectious viruses at the epithelial surface (reviewed in [15]).”
Zhang, L., Tan, W., Yang, H., Zhang, S., & Dai, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.831949 · Cited by 62
“Therefore, the consequences of HR-HPV infection vary upon how cervical epithelial cells are exposed to HR-HPV, including transient, productive, and transforming infections (25).”
BackgroundEarly risk prediction of cervical cancer: A machine learning approach
Ratul, I. J., Al-Monsur, A., Tabassum, B., Ar-Rafi, A. M., Nishat, M. M., & Faisal, F. (2022) · International Conference on Electrical Engineering/Electronics, Computer, Telecommunications and Information Technology (ECTI-CON) · doi:10.1109/ecti-con54298.2022.9795429 · Cited by 57
Epigenetic mechanisms in virus-induced tumorigenesis
Poręba, E., Broniarczyk, J. K., & Goździcka‐Józefiak, A. (2011) · Clinical Epigenetics · doi:10.1007/s13148-011-0026-6 · Cited by 61
“HPV are small non-enveloped DNA viruses which infect epithelial cells and their life cycle depends on epithelial differentiation and viral–host protein interaction (Doorbar 2005, 2006).”
BackgroundDisrupted human–pathogen co-evolution: a model for disease
Kodaman, N., Sobota, R. S., Mera, R. M., Schneider, B., & Williams, S. M. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00290 · Cited by 68
“Of note, E6 and E7 interfere with the human tumor suppressor proteins, pRB and p53 (Dyson et al., 1989; Huibregtse et al., 1993a,b; Storey et al., 1998; Munger et al., 2004; Doorbar, 2006).”
BackgroundInnate immunity and HPV: friends or foes
Nunes, R. A. L., Morale, M. G., Silva, G. Á. F., Villa, L. L., & Termini, L. (2018) · Clinics · doi:10.6061/clinics/2018/e549s · Cited by 61
“These oncoproteins, especially E6 and E7, induce continuous cell proliferation and prevent apoptosis, thus favoring the accumulation of mutations in the host genome due to the inhibition of pRb and p53 function (36).”
BackgroundLaboratory and clinical aspects of human papillomavirus testing
Chan, P. K. S., Picconi, M. A., Cheung, T. H., Giovannelli, L., & Park, J. S. (2012) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.707174 · Cited by 63
van Baars, R., van der Marel, J., Snijders, P. J. F., Rodríguez-Manfredi, Á., ter Harmsel, B., van den Munckhof, H. A. M., Ordï, J., Pino, M. L. D., van de Sandt, M. M., Wentzensen, N., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29706 · Cited by 57
“As a result, high expression levels of the viral oncogenes E6 and E7 in dividing epithelial cells trigger an oncogenic condition (a so-called transforming infection), which is often morphologically characterized as highgrade CIN (HG-CIN; CIN2/CIN3).(5) Progression of highgrade lesions to invasive cervical cancer requi…”
BackgroundBiology and natural history of human papillomavirus infection
Fernandes, J. V., de Araújo, J. M. G., & Fernandes, T. A. A. D. M. (2013) · Open Access Journal of Clinical Trials · doi:10.2147/oajct.s37741 · Cited by 70
Wang, C., Lai, C., Huang, H., Chao, A., Chang, C., Chang, T., Chou, H., & Hong, J. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.09.021 · Cited by 57
Saha, S. K., & Khuda‐Bukhsh, A. R. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.09.048 · Cited by 55
Hassuna, N. A., Monk, P. N., Moseley, G. W., & Partridge, L. J. (2009) · BioDrugs · doi:10.2165/11315650-000000000-00000 · Cited by 63
“[133] However, some types, notably HPV16, are directly related to the development of cancers of the lower female genital tract, especially cervical carcinoma.”
BackgroundNor Rashid, N., Yusof, R., & Watson, R. J. (2011) · Journal of General Virology · doi:10.1099/vir.0.035352-0 · Cited by 54
Egawa, N., Wang, Q., Griffin, H. M., Murakami, I., Jackson, D. J., Mahmood, R., & Doorbar, J. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006282 · Cited by 55
Self-citationOxidative stress: therapeutic approaches for cervical cancer treatment
Silva, G. Á. F., Nunes, R. A. L., Morale, M. G., Boccardo, E., Aguayo, F., & Termini, L. (2018) · Clinics · doi:10.6061/clinics/2018/e548s · Cited by 63
Human Papillomavirus and Oropharyngeal Cancer: What You Need to Know in 2009
Gillespie, M. B., Rubinchik, S., Hoel, B. D., & Sutkowski, N. (2009) · Current Treatment Options in Oncology · doi:10.1007/s11864-009-0113-5 · Cited by 54
“The integration event frequently disrupts regulation of E6 and E7 expression subsequently resulting in their increased expression [ 7 ].”
BackgroundInfluentialOsborne, S. L., Tabrizi, S. N., Brotherton, J. M. L., Cornall, A. M., Wark, J. D., Wrede, C. D., Jayasinghe, Y., Gertig, D. M., Pitts, M. K., & Garland, S. M. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.10.045 · Cited by 57
Palmer, E., Newcombe, R. G., Green, A. C., Kelly, C., Gill, O. N., Hall, G. L., Fiander, A., Pirotte, E., Hibbitts, S. J., Homer, J. J., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28886 · Cited by 58
“The existence of such lesions was hypothesised largely by analogy to cervical neoplasia, where prolonged persistent HPV infection is often associated with CIN.16 The absence of HPV-associated neoplasia in this study does not prove that it did not occur, but suggests that it may be uncommon without subsequent developme…”
BackgroundHecht, M., Harrer, T., Büttner, M., Schwegler, M., Erber, S., Fietkau, R., & Distel, L. V. (2013) · AIDS · doi:10.1097/qad.0b013e3283625444 · Cited by 53
“In the tumourigenesis of cervical cancer, the human papilloma virus (HPV) infection is an essential step, because HPV protein E6 leads to a degradation of the tumour suppressor protein p53 [56].”
BackgroundMadkan, V. K., Cook‐Norris, R. H., Steadman, M. C., Arora, A., Mendoza, N., & Tyring, S. K. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07961.x · Cited by 53
Domain‐mediated protein interaction prediction: From genome to network
Reimand, J., Hui, S., Jain, S., Law, B., & Bader, G. D. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.027 · Cited by 56
Lecavalier‐Barsoum, M., Chaudary, N., Han, K. C.-Z., Koritzinsky, M., Hill, R. P., & Milosevic, M. (2018) · International Journal of Cancer · doi:10.1002/ijc.31297 · Cited by 55
Liu, M.-C., Chen, W.-H., Wu, L.-C., Hsu, W.-C., Lo, W., Yeh, S.-D., Wang, M.-F., Zeng, R., & Deng, W. (2013) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2013.0048 · Cited by 52
“Immortalizing cells with human papillomavirus-16 E6/E7 (HPV-16 E6/E7) efficaciously extend the stage of growth before senescence well beyond normal.(25) Previously, we have successfully established hPi cells, an immortalized human articular chondrocytes by HPV-16 E6/ E7, preserving the relevant features without neopla…”
The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus Pathogenesis
Meuris, F., Carthagéna, L., Jaracz‐Ros, A., Gaudin, F., Cutolo, P., Deback, C., Xue, Y., Thierry, F., Doorbar, J., & Bachelerie, F. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1006039 · Cited by 56
Self-citationThe Tetraspanin CD151 in Papillomavirus Infection
Scheffer, K. D., Berditchevski, F., & Florin, L. (2014) · Viruses · doi:10.3390/v6020893 · Cited by 51
“The early genes E1, E2, E4, E5, E6 and E7 are non-structural viral proteins responsible for viral replication and transcription, as well as for transformation, segregation and tumorigenesis [1,4,5].”
BackgroundHPV Clearance and the Neglected Role of Stochasticity
Ryser, M. D., Myers, E. R., & Durrett, R. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004113 · Cited by 51
“New HPV infections arise in the basal layer of the SSE: physical ruptures in the tissue allow virions to reach the bottom layer of the SSE, where they infect residing S and D cells [16].”
BackgroundInfluentialKim, M. S., Bak, Y., Park, Y. S., Lee, D. H., Kim, J. H., Kang, J. W., Song, H., Oh, S., & Yoon, D. Y. (2013) · Cell Biology and Toxicology · doi:10.1007/s10565-013-9251-4 · Cited by 51
High-Risk Human Papillomavirus Targets Crossroads in Immune Signaling
Tummers, B., & van der Burg, S. (2015) · Viruses · doi:10.3390/v7052485 · Cited by 51
“The loss of these tumor suppressors results in uncontrollable cell growth, host genome mutations and inhibition of apoptosis, ultimately leading to cancer formation [1,13,14].”
BackgroundGanti, K., Massimi, P., Manzo-Merino, J., Tomaić, V., Pim, D., Playford, M. P., Lizano, M., Roberts, S., Kranjec, C., Doorbar, J., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005854 · Cited by 50
Self-citation
Metadata
- Authors
- Doorbar, J.
- Affiliations
- National Institute for Medical Research (GB)
- Corresponding author
- Doorbar, John
- ORCID
- Doorbar, John
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2006-04-11
- Volume
- 110
- Issue
- 5
- Pages
- 525-541
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2052489835
- Cited by
- 1,072
- References
- 179
- Citations by year
- 2026: 30 · 2025: 35 · 2024: 34 · 2023: 41 · 2022: 51 · 2021: 43 · 2020: 52 · 2019: 45 · 2018: 60 · 2017: 55 · 2016: 58 · 2015: 64 · 2014: 73 · 2013: 98 · 2012: 83
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human papillomavirus, cervical cancer, HPV16, high-risk HPV, viral gene expression, cervical neoplasia, cervical transformation zone, E6 oncoprotein, E7 oncoprotein, retinoblastoma protein, p53 degradation, PDZ domain proteins, abortive infection, viral latency, immune clearance
- MeSH terms
- Uterine Cervical Neoplasms, Female, Humans, Precancerous Conditions, Virus Latency, Disease Progression, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.